TG Therapeutics, Inc. (TGTX)
Market Closed
3 Jun, 20:00
$
40. 11
+3.47
+9.47%
$
5.73B Market Cap
- P/E Ratio
- Div Yield
3,622,000 Volume
0.03 Eps
$ 36.64
Previous Close 
Want to track TGTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TG Therapeutics, Inc. (TGTX) Statistics
Valuation metrics
Market Cap 5.73B
Enterprise value 5.47B
Trailing P/E (ttm) 13.1
Forward P/E 15.27
PEG ratio 15.27
Price/Sales (ttm) 9.4
Price/Book (mrq) 8.02
Enterprise Value/Revenue 8.88
Enterprise Value/EBITDA 44.34
Overview
Shares outstanding 155.31M
Float 140.95M
Shares short 28.94M
% Held by insiders 0.07%
% Held by institutions 0.66%
Average volume (10 days) 1.73M
Average volume (90 days) 2.09M
Price summary
52-Week low 25.28
52-Week high 44.65
Beta 1.75
50-Day moving average 31.1
200-Day moving average 31.95
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 100:5,625
Last split Date 30 Apr 2012
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.73%
Operating margin 0.26%
Operational effectiveness
Return on assets 0.09%
Return on equity 1.03%
Income Statement
Revenue (ttm) 616.29M
Revenue per share (ttm) 4.27
Quarterly revenue growth (yoy) 0.78%
Gross profit (ttm) 515.57M
EBITDA 134.36M
Net income to common (ttm) 447.18M
Diluted EPS (ttm) 2.77
Quarterly earnings growth (yoy) -0.01%
Balance Sheet
Total cash (mrq) 141.97M
Total cash per share (mrq) 0.96
Total debt (mrq) 254.4M
Total Debt/Equity (mrq) 39.26
Current ratio (mrq) 4.1%
Book value per share (mrq) 4.52
Cash Flow
Cash flow statement -24.77M
Levered free cash flow (LFCF) -43.98M
